Внутрибрюшинная биотерапия с использованием интерлейкина-2 и донорских ЛАК-клеток при метастатических асцитах у больных раком яичников

Титов Константин Сергеевич, М В Киселевский, Лев Вадимович Демидов et al. · Российский биотерапевтический журнал · 2011

Malignant peritoneal effusions often arise in patients with ovarian cancer which is considered to be a dangerous complication of cancer. Intraperitoneal chemotherapy is uneffective in generally and causes side effects. Here we show that intraperitoneal IL-2/lymphokine activated killers and IL-2 biotherapy demonstrated the high efficacy in threatment of ovarian cancer patients with malignant peritoneal effusions. The objective effect was 82,6 % аnd 70,6 % accordingly. These results indicates that intraperitoneal biotherapy might be one of the stages of combined treatment of such group of patients The suggested type of biotherapy increases the survival and life quality of patients.

Cited by 0 works.

Authors